Cargando…

New insights into small‐cell lung cancer development and therapy

Small‐cell lung cancer (SCLC) accounts for approximately 15% of lung cancer cases; however, it is characterized by easy relapse and low survival rate, leading to one of the most intractable diseases in clinical practice. Despite decades of basic and clinical research, little progress has been made i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuwen, Zou, Songyun, Zhao, Zhuyun, Liu, Po, Ke, Changneng, Xu, Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496722/ https://www.ncbi.nlm.nih.gov/pubmed/32281704 http://dx.doi.org/10.1002/cbin.11359

Ejemplares similares

Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells
por: Zhao, Zhuyun, et al.
Publicado: (2021)

Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development
por: Cheng, Ke, et al.
Publicado: (2021)

A case of concentrated growth factor gel to fill the defect after large jaw cyst enucleation
por: Chen, Binxiong, et al.
Publicado: (2023)

New insights into the important roles of phase seperation in the targeted therapy of lung cancer
por: Zou, Ying, et al.
Publicado: (2023)

New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment
por: Jiang, Piao, et al.
Publicado: (2023)

Immunotherapy in non-small cell lung cancer: Update and new insights
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2021)

An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer
por: Qi, Yuwen, et al.
Publicado: (2023)

Melatonin and non-small cell lung cancer: new insights into signaling pathways
por: Pourhanifeh, Mohammad Hossein, et al.
Publicado: (2019)

Pyroptosis: A new insight of non-small-cell lung cancer treatment
por: Chen, Xi, et al.
Publicado: (2022)

Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer
por: Shen, Jie, et al.
Publicado: (2023)

J147 ameliorates sepsis-induced depressive-like behaviors in mice by attenuating neuroinflammation through regulating the TLR4/NF-κB signaling pathway
por: Qiu, Fang, et al.
Publicado: (2023)

New Targeted Therapy for Non-Small Cell Lung Cancer
por: Chung, Eun Ki, et al.
Publicado: (2023)

New Insights into the Epigenomic Landscape of Small-Cell Lung Cancer: A Game Changer?
por: Sarode, Poonam, et al.
Publicado: (2022)

Targeted therapies in development for non-small cell lung cancer
por: Reungwetwattana, Thanyanan, et al.
Publicado: (2013)

Development of Small RNA Delivery Systems for Lung Cancer Therapy
por: Fujita, Yu, et al.
Publicado: (2015)

Serum MiR-4687-3p Has Potential for Diagnosis and Carcinogenesis in Non-small Cell Lung Cancer
por: Liu, Man, et al.
Publicado: (2020)

Nonsmall Cell Lung Cancer Therapy: Insight into Multitargeted Small-Molecule Growth Factor Receptor Inhibitors
por: Roy, Mridul, et al.
Publicado: (2013)

Sirt3 Promoted DNA Damage Repair and Radioresistance Through ATM-Chk2 in Non-small Cell Lung Cancer Cells
por: Cao, Kun, et al.
Publicado: (2021)

Biological insights in non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Signal pathways and precision therapy of small-cell lung cancer
por: Yuan, Min, et al.
Publicado: (2022)

Apatinib Monotherapy or Combination Therapy for Non-Small Cell Lung Cancer Patients With Brain Metastases
por: Xu, Jianping, et al.
Publicado: (2020)

Targeted therapy and non-small cell lung cancer: a new era!
por: Malapelle, Umberto, et al.
Publicado: (2019)

New insights into the interaction of the immune system with non-small cell lung carcinomas
por: Hofman, Paul
Publicado: (2020)

Drugs in development for small cell lung cancer
por: Serzan, Michael T., et al.
Publicado: (2020)

Emerging therapies for non-small cell lung cancer
por: Zhang, Chao, et al.
Publicado: (2019)

Newly developed anti-angiogenic therapy in non-small cell lung cancer
por: Qu, Jingjing, et al.
Publicado: (2017)

Construction and validation of a prognostic risk model of angiogenesis factors in skin cutaneous melanoma
por: Zou, Songyun, et al.
Publicado: (2022)

Genetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors
por: Shi, Xiaohua, et al.
Publicado: (2016)

Current evidence for J147 as a potential therapeutic agent in nervous system disease: a narrative review
por: Qiu, Fang, et al.
Publicado: (2023)

Observation and Nursing of Adverse Reactions in Severe Patients with Enhanced MRI
por: Dai, Yehua, et al.
Publicado: (2022)

Bis(acetylacetonato)oxido(triphenylphosphine oxide)vanadium(IV)
por: Chen, Hui, et al.
Publicado: (2007)

Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy
por: Cheng, Yuan, et al.
Publicado: (2021)

New insights into different adipokines in linking the pathophysiology of obesity and psoriasis
por: Kong, Yi, et al.
Publicado: (2019)

PD-1 inhibitors-associated myocarditis in non-small cell lung cancer patients
por: He, Yuwen, et al.
Publicado: (2023)

Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database
por: Yang, Lan, et al.
Publicado: (2021)

Multifaceted Roles of Caveolin-1 in Lung Cancer: A New Investigation Focused on Tumor Occurrence, Development and Therapy
por: Shi, Yu-Bo, et al.
Publicado: (2020)

Inhibition of PC4 radiosensitizes non‐small cell lung cancer by transcriptionally suppressing XLF
por: Zhang, Tian, et al.
Publicado: (2018)

Emerging therapies for small cell lung cancer
por: Yang, Sen, et al.
Publicado: (2019)

New insights into the biology and development of lung cancer in never smokers—implications for early detection and treatment
por: Wang, Peiyao, et al.
Publicado: (2023)

Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9stajkecqq2mbhstdpmg39dd7j